While actual breast cancer risk differs by study design and case selection, the most comprehensive updated risk estimates are 72% and 69% lifetime risk for BRCA1 and BRCA2 PSV carriers, respectively [1]. This evidence concerns the gene BRCA1 and breast carcinoma.